Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

Salem Investment Counselors Inc. trimmed its position in Medtronic plc (NYSE:MDT – Free Report) by 17.1% in the fourth ...

Medtronic Vietnam and the University Medical Center Ho Chi Minh City (UMC HCMC) have signed their fourth Memorandum of ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price target of ...

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its BrainSense adaptive deep brain stimulation ...

Overall, Medtronic's dividend is safe for now, but there may be better income-generating investments out there to choose from ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its medical device. The ...

Medtronic Vietnam and University Medical Center Ho Chi Minh City (UMC) signed their fourth MoU on January 13 to advance ...

Medtronic is picking up steam with recent product launches, and its balance sheet is a fortress. Read more about MDT stock ...

Medtronic offers solid income potential with a 3.5% dividend yield. Read why MDT stock’s forward P/E ratio signals possible ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Medtronic (MDT – Research Report) today and set a price target of $95.00. The ...